Racial/Ethnic and Poverty Disparitie HPV
Posted on 11/16/2011
Racial/Ethnic and Poverty Disparities in Human Papillomavirus Vaccination Completion Background: Two vaccines against human papillomavirus (HPV), a necessary cause of cervical cancer, are currently licensed and recommended for routine administration in the U.S. to girls in a three-doseseries.
Purpose: This study examined effects of race/ethnicity, poverty, and year on completion of the three-doseHPVvaccineseriesamongthosewhoinitiatedvaccination.
Methods: Datafromthe2008–2009 National Immunization Survey-Teen for girls aged 13–17 years who received atleast one dose of HPV vaccine(n=7606)wereanalyzed in 2010–2011 usinglogistic regressiontoadjustforcovariatesincludingmeasuresofaccesstocare.
Results: Duringthis2-yearperiod,55%ofadolescentgirlswhoinitiatedvaccinationcompletedthe three-dose series. Completion was signifıcantly higher in 2009 (60%) compared to 2008 (48%;p$75,000 (AOR=0.76, 95% CI=0.63, 0.92). There was no signifıcant interaction between race/ethnicity and year (p=0.92).
Although poverty was associated with lower completion rates in 2008, this association was not observedin2009(p
Conclusions: HPV vaccination completion rates increased between 2008 and 2009. However, signifıcantdifferencesbyrace/ethnicityandpovertywereobserved,andtheracial/ethnicdifferences persisted.
Linda M. Niccolai, PhD, Niti R. Mehta, MPH, James L. Hadler, MD, MPH
(AmJPrevMed2011;41(4):428–433)
